MedTrace Logo

Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers

NCT04567745 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-11-01

No results posted yet for this study

Summary

This study aims to provide clinical validation of EyeQuant, a fully automated retinal image analysis system for computation of vascular biomarkers indicative of cognitive disorders, using retinal fundus photographs collected from patients with mild cognitive impairment, Alzheimer's disease, and vascular dementia.

Conditions

Interventions

DIAGNOSTIC_TEST

Retinal fundus photography

Fundus photographs

Sponsors & Collaborators

  • Eyenuk, Inc.

    collaborator INDUSTRY

  • Malavika Bhaskaranand PhD

    collaborator UNKNOWN

  • Kaushal Solanki

    collaborator UNKNOWN

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Oana Dumitrascu, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-29
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04567745 on ClinicalTrials.gov